Warkem Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 4.89 Cr
as on 07-12-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.00 Cr
as on 07-12-2024
- Satisfied Charges ₹ 15.80 Cr
as on 07-12-2024
- Revenue 15.39%
(FY 2023)
- Profit -14.92%
(FY 2023)
- Ebitda -1.06%
(FY 2023)
- Net Worth 4.52%
(FY 2023)
- Total Assets 6.21%
(FY 2023)
About Warkem Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.89 Cr.
The company currently has active open charges totaling ₹19.00 Cr. The company has closed loans amounting to ₹15.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gangadhar Warke, Saroj Warke, Ramesh Warke, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U24200MH2005PTC150416
- Company No.
150416
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Warkem Biotech Private Limited offer?
Warkem Biotech Private Limited offers a wide range of products and services, including Fertilizer, Amino Acids, Nutraceuticals & Dietary Supplements, Fitness Supplements, Content Writing Service, Research Development Services, Chemical Reagents & Catalysts, Bio Chemicals, ISO & Quality Management Consultants, Certification Services.
Who are the key members and board of directors at Warkem Biotech?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Warke  | Director | 03-Dec-2014 | Current |
| Rajas Warke | Director | 03-Dec-2014 | Current |
| Gangadhar Warke | Director | 29-Sep-2014 | Current |
| Saroj Warke | Whole-Time Director | 05-Jan-2005 | Current |
| Ramesh Warke | Whole-Time Director | 05-Jan-2005 | Current |
| Vishnu Warke | Director | 29-Sep-2014 | Current |
Financial Performance and Corporate Structure Insights of Warkem Biotech.
Warkem Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.39% increase. The company also saw a substantial fall in profitability, with a 14.92% decrease in profit. The company's net worth moved up by a moderate rise of 4.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Warkem Biotech?
In 2023, Warkem Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himedia Laboratories Private LimitedActive 42 years 3 monthsGangadhar Warke, Saroj Warke and 8 more are mutual person
Promino Health Products Pvt LtdActive 40 years 1 dayGangadhar Warke, Vishnu Warke and 1 more are mutual person
- Pure Nutriplant Chemicals Pvt LtdActive 42 years 8 months
Vishnu Warke, Vishal Warke and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 13 May 2005 | ₹19.00 Cr | Open |
State Bank Of India Creation Date: 27 Dec 2005 | ₹15.80 Cr | Satisfied |
How Many Employees Work at Warkem Biotech?
Warkem Biotech has a workforce of 151 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Warkem Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Warkem Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
